ID   BALM-27
AC   CVCL_5703
DR   JCRB; JCRB1821
DR   Wikidata; Q54753203
RX   PubMed=12389627;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 32 hours (PubMed=12389627).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1821
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
RX   PubMed=12389627; DOI=10.1080/1042819022386761;
RA   Matsuo Y., Drexler H.G., Takeuchi M., Orita K.;
RT   "A novel L3-acute lymphoblastic leukemia cell line (BALM-27) carrying
RT   cytoplasmic immunoglobulin 8 chain but lacking expression of cell
RT   surface immunoglobulin chains.";
RL   Leuk. Lymphoma 43:1441-1446(2002).
//